77 results on '"Mihaylova I"'
Search Results
2. PO-1474 Lower FDG PET/CТ SUV max shows better response to SBRT of adrenals in oligometastatic disease
3. Phase equilibria in the PbSb 2Te 4–InSb system
4. PO-0944 Correlation on G8 score with sarcopenia is a prognostic factor for OS in patients with HNC
5. ANALYSIS OF FOREIGN EXPERIENCE OF SECONDARY CONSTRUCTION OF BUILDINGS FOR CULTURAL CENTERS INCLUDING CONCERT SPACE
6. LANDSCAPE URBANISM – A NEW DIRECTION OF MODERN CONCEPTS OF UR-BAN SPACE DEVELOPMENT ON THE EXAMPLE OF RUSSIAN CITIES
7. EP-1619 SBRT and the treatment of adrenal gland metastasis
8. Integrated Method of the Computation of Cooling Systems for Gas Turbine Rotors
9. EP-1273: Comparison of intensity modulated radiotherapy and 3D conformal radiotherapy in patients with cancer of anal canal
10. EP-1128: Prevention and treatment of acute radiodermatitis with Water Jel R1 and R2
11. EP-0973 REDUCING HEART IRRADIATION IN PATIENTS UNDERGOING CONFORMAL POSTOPERATIVE RADIOTHERAPY FOR LEFT BREAST CANCER
12. Phase equilibria in the PbSb2Te4–InSb system
13. 885 poster COMPARATIVE ANALYSIS OF TWO RADIOTHERAPY REGIMENS FOR THE TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER
14. 1069 poster PREOPERATIVE RADIOCHEMOTHERAPY WITH CAPECITABINE VERSUS RADIOTHERAPY ALONE IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
15. IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology.
16. PROTECTIVE, ELECTIVE LUNG IRRADIATION IN NON-METASTATIC EWING'S SARCOMA.
17. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: Evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells
18. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome
19. Not in the mind but in the cell: Increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome
20. Coenzyme Q10 deficiency in myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder
21. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): Relevance for the inflammatory response in CFS
22. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: Docosahexaenoicacid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response
23. Lower plasma Coenzyme Q10 in depression: A marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness
24. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins
25. Not in the mind of neurasthenic lazybones but in the cell nucleus: Patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta
26. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): Relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation
27. Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression
28. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS
29. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation
30. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: Another pathway that may be associated with coronary artery disease and neuroprogression in depression
31. Phase equilibria in the PbSb2Te4–InSb system
32. Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic disease.
33. COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information.
34. Ipsilateral in-breast tumor recurrence after breast conserving therapy: true recurrence versus new primary tumor.
35. SPECT-CT in Radiotherapy Planning, with Main Reference to Patients with Breast Cancer.
36. Radiation-induced breast cancer in women with Hodgkin's disease.
37. Primary angiosarcoma of the breast complicated by the syndrome of disseminated intravascular coagulation (DIC): Case report and literature review.
38. Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression.
39. [Dysgerminoma of the ovary. Presentation of case report].
40. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
41. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.
42. Degree of tumor regression after preoperative chemo-radiotherapy in locally advanced rectal cancer-Preliminary results.
43. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
44. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease.
45. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.
46. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
47. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.
48. An IgM-mediated immune response directed against nitro-bovine serum albumin (nitro-BSA) in chronic fatigue syndrome (CFS) and major depression: evidence that nitrosative stress is another factor underpinning the comorbidity between major depression and CFS.
49. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response.
50. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.